T. Rowe Price Health Care ETF (TMED) Holdings
TMED holdings summary
as of Oct 25, 2026- Holdings
- 105 positions listed
- Top 10 weight
- 38.9% of net assets
- Effective holdings
- 40 equal-weight equivalent
- Largest holding
- LLY 6.33% Eli Lilly and Company
- Annual turnover
- — of the portfolio traded
Top 1038.9%
Top 2567.7%
Top 5087.6%
Top 10098.7%
All TMED holdings
105 holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 6.33% | $2.2M | $1.12T | 42.2 |
| 2 | UNH | UnitedHealth Group Incorporated | Healthcare | 5.46% | $1.9M | $360.32B | 25.8 |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 5.11% | $1.8M | $31.02B | 39.1 |
| 4 | PODD | Insulet Corporation | Healthcare | 3.78% | $1.3M | $9.79B | 26.4 |
| 5 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 3.47% | $1.2M | $255.13B | 37.1 |
| 6 | GILD | Gilead Sciences, Inc. | Healthcare | 3.26% | $1.1M | $193.67B | — |
| 7 | ISRG | Intuitive Surgical, Inc. | Healthcare | 3.07% | $1.1M | $150.74B | 48.9 |
| 8 | A | Agilent Technologies, Inc. | Healthcare | 3.05% | $1.1M | $48.77B | 34.1 |
| 9 | WST | West Pharmaceutical Services, Inc. | Healthcare | 2.72% | $940,005.16 | $27.03B | 49.4 |
| 10 | COR | Cencora | Healthcare | 2.68% | $924,688.55 | $65.06B | 25.3 |
| 11 | ELAN | Elanco Animal Health Incorporated | Healthcare | 2.59% | $894,055.33 | $11.76B | — |
| 12 | ASND | Ascendis Pharma A/S | Healthcare | 2.42% | $835,755.62 | $14.82B | 17.3 |
| 13 | DHR | Danaher Corporation | Healthcare | 2.34% | $806,191.81 | $161.01B | 40.8 |
| 14 | WAT | Waters Corporation | Healthcare | 2.33% | $804,501.46 | $42.90B | 110.6 |
| 15 | CYTK | Cytokinetics, Incorporated | Healthcare | 2.30% | $794,083.40 | $8.61B | — |
| 16 | PCVX | Vaxcyte, Inc. | Healthcare | 1.90% | $656,923.86 | $10.01B | — |
| 17 | BSX | Boston Scientific Corporation | Healthcare | 1.87% | $645,712.38 | $64.33B | 18.0 |
| 18 | DXCM | DexCom, Inc. | Healthcare | 1.81% | $623,151.42 | $32.47B | 34.1 |
| 19 | DNLI | Denali Therapeutics Inc. | Healthcare | 1.75% | $605,040.57 | $2.81B | — |
| 20 | MLTX_old | Multex Com Inc | Other | 1.71% | $591,310.81 | — | — |
| 21 | DYN | Dyne Therapeutics, Inc. | Healthcare | 1.64% | $564,127.28 | $2.66B | — |
| 22 | STTK | Shattuck Labs, Inc. | Healthcare | 1.57% | $541,911.30 | $544.0M | — |
| 23 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 1.52% | $525,732.27 | $44.20B | 39.8 |
| 24 | ABT | Abbott Laboratories | Healthcare | 1.51% | $520,557.74 | $181.50B | 33.8 |
| 25 | MCK | McKesson Corporation | Healthcare | 1.47% | $508,173.36 | $117.15B | 26.9 |
| 26 | CABA | Cabaletta Bio, Inc. | Healthcare | 1.44% | $496,064.96 | $239.1M | — |
| 27 | BIIB | Biogen Inc. | Healthcare | 1.41% | $486,785.30 | $34.37B | 41.3 |
| 28 | IMNM | Immunome, Inc. | Healthcare | 1.26% | $436,040.41 | $1.94B | — |
| 29 | RVTY | Revvity, Inc. | Healthcare | 1.05% | $362,803.56 | $17.03B | 73.0 |
| 30 | HUM | Humana Inc. | Healthcare | 1.05% | $362,286.11 | $49.61B | 39.1 |
| 31 | ADPT | Adaptive Biotechnologies Corporation | Healthcare | 0.95% | $328,272.20 | $3.83B | — |
| 32 | CVS | CVS Health Corporation | Healthcare | 0.89% | $307,608.57 | $118.13B | 24.3 |
| 33 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 0.84% | $288,221.33 | $4.76B | — |
| 34 | ERAS | Erasca, Inc. | Healthcare | 0.78% | $270,110.48 | $4.68B | — |
| 35 | CGON | CG Oncology, Inc. | Healthcare | 0.78% | $267,350.73 | $5.31B | — |
| 36 | OKUR | OnKure Therapeutics, Inc. | Healthcare | 0.77% | $267,109.25 | $85.0M | — |
| 37 | RGEN | Repligen Corporation | Healthcare | 0.74% | $254,276.41 | $11.14B | 240.3 |
| 38 | BNTX | BioNTech SE | Healthcare | 0.72% | $248,032.48 | $22.03B | — |
| 39 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 0.70% | $241,236.60 | $7.14B | — |
| 40 | IMTX | Immatics N.V. | Healthcare | 0.69% | $238,269.87 | $1.02B | — |
| 41 | PRME | Prime Medicine, Inc. | Healthcare | 0.67% | $232,577.88 | $629.4M | — |
| 42 | FRNM | Freenome, Inc. | Healthcare | 0.64% | $219,607.06 | $1.26B | — |
| 43 | SRT | Sartorius Aktiengesellschaft | Healthcare | 0.63% | $218,330.68 | — | — |
| 44 | BLLN | BillionToOne, Inc. | Healthcare | 0.60% | $205,325.36 | $4.63B | 155.7 |
| 45 | CAH | Cardinal Health, Inc. | Healthcare | 0.59% | $204,911.40 | $58.83B | 35.1 |
| 46 | KOD | Kodiak Sciences Inc. | Healthcare | 0.59% | $202,151.65 | $5.39B | — |
| 47 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 0.58% | $199,046.93 | $3.24B | — |
| 48 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.56% | $194,286.36 | $32.51B | 36.6 |
| 49 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 0.52% | $178,555.79 | $4.03B | — |
| 50 | IRON | Disc Medicine, Inc. | Healthcare | 0.46% | $159,755.00 | $2.18B | — |
| 51 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 0.45% | $154,580.47 | $800.8M | — |
| 52 | KLRA | Kailera Therapeutics, Inc. | Healthcare | 0.45% | $154,166.50 | $1.46B | — |
| 53 | AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | 0.41% | $142,679.05 | $3.31B | — |
| 54 | KARD | Kardigan, Inc. | Healthcare | 0.39% | $134,330.80 | $1.22B | — |
| 55 | SYK | Stryker Corporation | Healthcare | 0.38% | $132,226.50 | $113.02B | 30.5 |
| 56 | BCAX | Bicara Therapeutics Inc. | Healthcare | 0.38% | $131,364.07 | $1.11B | — |
| 57 | ELV | Elevance Health Inc. | Healthcare | 0.38% | $130,950.11 | $92.88B | 19.0 |
| 58 | INCY | Incyte Corporation | Healthcare | 0.34% | $117,772.31 | $22.92B | 14.4 |
| 59 | VOR | Vor Biopharma Inc. | Healthcare | 0.34% | $117,082.37 | $977.0M | 0.1 |
| 60 | CBIO | Crescent Biopharma, Inc. | Healthcare | 0.33% | $114,805.58 | $439.8M | — |
| 61 | MAZE | Maze Therapeutics, Inc. | Healthcare | 0.31% | $107,630.23 | $1.53B | — |
| 62 | AVLN | Avalyn Pharma Inc. | Healthcare | 0.31% | $107,561.23 | $1.05B | — |
| 63 | SLDB | Solid Biosciences Inc. | Healthcare | 0.31% | $107,457.74 | $593.0M | — |
| 64 | LEGN | Legend Biotech Corporation | Healthcare | 0.31% | $107,181.77 | $3.59B | — |
| 65 | IMVT | Immunovant, Inc. | Healthcare | 0.31% | $105,594.91 | $5.52B | — |
| 66 | STOK | Stoke Therapeutics, Inc. | Healthcare | 0.30% | $103,732.08 | $1.56B | — |
| 67 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 0.30% | $103,456.11 | $8.62B | — |
| 68 | BCTG | BCTG Acquisition Corp | Financial Services | 0.29% | $100,109.91 | — | — |
| 69 | AKTS | Akoustis Technologies, Inc. | Healthcare | 0.29% | $99,075.00 | $837.6M | — |
| 70 | OSCR | Oscar Health, Inc. | Healthcare | 0.27% | $94,728.40 | $9.84B | 24.7 |
| 71 | CADL | Candel Therapeutics, Inc. | Healthcare | 0.25% | $87,932.52 | $626.7M | — |
| 72 | NGNE | Neurogene Inc. | Healthcare | 0.24% | $81,240.12 | $465.3M | — |
| 73 | BDTX | Black Diamond Therapeutics, Inc. | Healthcare | 0.22% | $75,824.12 | $98.8M | — |
| 74 | TECX | Tectonic Therapeutic Inc. | Healthcare | 0.22% | $74,685.72 | $403.7M | — |
| 75 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.21% | $74,168.27 | $13.79B | 19.9 |
| 76 | ROIV | Roivant Sciences Ltd. | Healthcare | 0.21% | $71,374.02 | $24.22B | — |
| 77 | MPLT | MapLight Therapeutics, Inc. | Healthcare | 0.20% | $70,442.60 | $427.9M | — |
| 78 | STVN | Stevanato Group S.p.A. | Healthcare | 0.18% | $63,543.23 | $5.16B | 33.2 |
| 79 | CELC | Celcuity Inc. | Healthcare | 0.17% | $58,161.72 | $2.77B | — |
| 80 | LFST | LifeStance Health Group, Inc. | Healthcare | 0.17% | $57,368.29 | $4.46B | 90.3 |
| 81 | FDMT | 4D Molecular Therapeutics, Inc. | Healthcare | 0.17% | $57,126.81 | $670.7M | — |
| 82 | ALKS | Alkermes plc | Healthcare | 0.16% | $55,091.50 | $6.92B | 108.5 |
| 83 | MOH | Molina Healthcare, Inc. | Healthcare | 0.15% | $51,917.79 | $10.82B | — |
| 84 | TVTX | Travere Therapeutics, Inc. | Healthcare | 0.14% | $49,951.46 | $4.61B | — |
| 85 | DMRA | Damora Therapeutics, Inc. | Healthcare | 0.14% | $48,640.58 | $1.14B | — |
| 86 | RLAY | Relay Therapeutics, Inc. | Healthcare | 0.13% | $45,397.88 | $3.57B | — |
| 87 | ALLO | Allogene Therapeutics, Inc. | Healthcare | 0.12% | $42,465.64 | $452.6M | — |
| 88 | GRAL | GRAIL, Inc. | Healthcare | 0.12% | $42,224.17 | $5.26B | — |
| 89 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.12% | $39,809.39 | $14.46B | — |
| 90 | PBLS | Parabilis Medicines, Inc. | Healthcare | 0.11% | $36,739.16 | $2.81B | — |
| 91 | ONC | BeiGene, Ltd. | Healthcare | 0.10% | $34,979.82 | $41.99B | 66.0 |
| 92 | CAI | Caris Life Sciences, Inc. | Healthcare | 0.10% | $33,082.50 | $8.64B | 18.1 |
| 93 | BHVN | Biohaven Ltd. | Healthcare | 0.09% | $31,254.16 | $1.63B | — |
| 94 | AVTX | Avalo Therapeutics, Inc. | Healthcare | 0.09% | $31,219.67 | $604.4M | — |
| 95 | EIKN | Eikon Therapeutics, Inc. | Healthcare | 0.09% | $31,185.17 | $401.9M | — |
| 96 | CRSP | CRISPR Therapeutics AG | Healthcare | 0.08% | $28,218.44 | $4.76B | — |
| 97 | SDGR | Schrödinger, Inc. | Healthcare | 0.07% | $25,631.17 | $1.69B | — |
| 98 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 0.07% | $25,389.69 | $2.73B | — |
| 99 | ANNX | Annexon, Inc. | Healthcare | 0.07% | $25,079.22 | $646.5M | — |
| 100 | RCUS | Arcus Biosciences, Inc. | Healthcare | 0.07% | $24,182.30 | $2.82B | — |
| 101 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | 0.06% | $20,249.66 | $1.81B | — |
| 102 | THC | Tenet Healthcare Corporation | Healthcare | 0.06% | $20,146.17 | $21.52B | 10.5 |
| 103 | RAPP | Rapport Therapeutics, Inc. | Healthcare | 0.06% | $19,145.76 | $1.32B | — |
| 104 | ORIC | ORIC Pharmaceuticals, Inc. | Healthcare | 0.05% | $18,662.81 | $1.28B | — |
| 105 | COO | The Cooper Companies, Inc. | Healthcare | 0.05% | $16,696.48 | $11.02B | 19.9 |
Weights as a percentage of net assets. Value held = weight × net assets ($34.5M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
TMED sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 97.0% | 103 | LLY, UNH, ALNY |
| Other | 1.7% | 1 | MLTX_old |
| Financial Services | 0.3% | 1 | BCTG |
Sum of the weights of the holdings in each sector.
TMED top industries
Biotechnology
35.9%
Diagnostics & Research
16.7%
Drug Manufacturers - General
11.0%
Medical Devices
9.4%
Healthcare Plans
8.2%
Medical Instruments & Supplies
7.4%
Medical Distribution
4.7%
Drug Manufacturers - Specialty & Generic
3.4%
Shell Companies
0.3%
Medical Care Facilities
0.2%
Health Information Services
0.1%
TMED overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF | 4.9% | 27 of 502 | 0.09% |
| DIA | SPDR Dow Jones Industrial Average ETF | 4.7% | 1 of 30 | 0.16% |
| VTI | Vanguard Total Stock Market ETF | 4.6% | 91 of 2,941 | 0.03% |
| IWM | iShares Russell 2000 ETF | 4.1% | 58 of 1,962 | 0.19% |
| QQQ | Invesco QQQ ETF | 2.0% | 5 of 101 | 0.17% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 5 of 8,035 | 0.05% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the TMED portfolio
T. Rowe Price Health Care ETF holds 105 positions. The ten largest make up 38.9% of the fund and the top 50 87.6%, so it behaves like a portfolio of about 40 equally weighted stocks. The biggest positions are Eli Lilly and Company (6.33%), UnitedHealth Group Incorporated (5.46%), Alnylam Pharmaceuticals, Inc. (5.11%), Insulet Corporation (3.78%), Thermo Fisher Scientific Inc. (3.47%).
By sector, Healthcare is 97.0%, Other is 1.7%, Financial Services is 0.3%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: TMED chart, TMED performance, TMED dividends, TMED overview.
TMED holdings FAQ
How many holdings does TMED have?
TMED holds 105 positions as of October 25, 2026.
What are the top 10 holdings of TMED?
The ten largest holdings are Eli Lilly and Company (6.33%), UnitedHealth Group Incorporated (5.46%), Alnylam Pharmaceuticals, Inc. (5.11%), Insulet Corporation (3.78%), Thermo Fisher Scientific Inc. (3.47%), Gilead Sciences, Inc. (3.26%), Intuitive Surgical, Inc. (3.07%), Agilent Technologies, Inc. (3.05%), West Pharmaceutical Services, Inc. (2.72%), Cencora (2.68%). Together they are 38.9% of the fund.
What percentage of TMED is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 6.33% of net assets, about $2.2M of the fund's $34.5M.
Which sector is the largest in TMED?
Healthcare is the largest sector at 97.0%, followed by Other (1.7%) and Financial Services (0.3%), based on the sectors of the individual holdings.
How concentrated is TMED?
The top 10 holdings are 38.9% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) TMED behaves like a portfolio of about 40 equally weighted stocks.